IGM Biosciences Inc (IGMS) — Strategic Asset Allocation Index
IGM Biosciences Inc (IGMS) has a Strategic Asset Allocation Index of 29.7% as of June 2023. Strategic assets (PP&E of $76.78 Million plus long-term investments of $-) total $76.78 Million, measured against net assets of $258.61 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See IGM Biosciences Inc (IGMS) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
IGM Biosciences Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how IGM Biosciences Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 29.7%, representing strategic assets of $76.78 Million against net assets of $258.61 Million USD. For live market cap and overall valuation, see how much is IGM Biosciences Inc worth.
Annual Strategic Asset Allocation Index for IGM Biosciences Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for IGM Biosciences Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See IGM Biosciences Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 25.4% | $73.08 Million | $73.08 Million | $- | $287.26 Million | ▲ +13.8 pp |
| 2021 | 11.6% | $28.50 Million | $28.50 Million | $- | $244.91 Million | ▲ +2.5 pp |
| 2020 | 9.1% | $34.81 Million | $34.81 Million | $0.00 | $381.81 Million | ▼ -3.4 pp |
| 2019 | 12.5% | $29.99 Million | $18.02 Million | $11.97 Million | $240.23 Million | — |